What happened
The CBS piece explains how the split started. Congress put most routine vaccines into VICP to keep makers in the market. During the pandemic, lawmakers used emergency law to protect suppliers and speed response. That same protection shifted the money and rules for COVID claims into the CICP.
Who wins here
Vaccine makers gain the clearest benefit. Emergency protections cut their legal exposure during a crisis. Health agencies also get breathing room to run mass vaccination without a wave of lawsuits. The trade-off falls on people who say they were harmed. They face a narrower program and fewer options for pain-and-suffering awards.
How the play works
uses law and program rules, not science. Congress created VICP in the 1980s after a scare over older vaccines. That program is judicial and no-fault. The PREP Act is an emergency law that shields manufacturers and pushes claims into an administrative program, the CICP. Administrative programs use stricter rules and shorter deadlines than courts.
Why it matters
This split changes who can get what and how fast. VICP lets claimants seek broader awards and has a longer time limit. CICP covers only serious injuries and pays less often. For people with real harms, the difference can mean no compensation, missed medical help, or long fights. For public health, the choice trades legal risk for steady supply during emergencies.
What to watch next
Watch for changes in law or rule-making. Congress can move COVID vaccines into VICP if it wants. Watch court rulings that test PREP Act limits. Also track CICP case numbers and payouts. That will show whether the emergency program is working for people who say they were hurt.